Ipsotian en es it fr

Ipsotian Brand names, Ipsotian Analogs

Ipsotian Brand Names Mixture

  • No information avaliable

Ipsotian Chemical_Formula


Ipsotian RX_link

No information avaliable

Ipsotian fda sheet

Ipsotian msds (material safety sheet)

Ipsotian Synthesis Reference

No information avaliable

Ipsotian Molecular Weight

309.469 g/mol

Ipsotian Melting Point

< 25 oC

Ipsotian H2O Solubility

Soluble as HCl salt

Ipsotian State


Ipsotian LogP


Ipsotian Dosage Forms

Tablets (oral, 1 mg)

Ipsotian Indication

Used for the symptomatic treatment of parkinsonism.

Ipsotian Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Ipsotian Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Ipsotian side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Ipsotian Patient Information

Ipsotian Organisms Affected

Humans and other mammals